Industry News

2409, 2026

Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™

September 24th, 2026|

eSTRAND RNA QC™ uses nanopore-based direct RNA sequencing to offer multi-attribute RNA characterization. Using direct RNA sequencing, eSTRAND RNA QC reads full-length RNA without requiring reverse transcription or translation. eSTRAND RNA QC simultaneously measures RNA identity, poly(A) tail length, ...

1009, 2026

Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™

September 10th, 2026|

eSTRAND RNA QC™ uses nanopore-based direct RNA sequencing to offer multi-attribute RNA characterization. Using direct RNA sequencing, eSTRAND RNA QC reads full-length RNA without requiring reverse transcription or translation. eSTRAND RNA QC simultaneously measures RNA identity, poly(A) tail length, ...

909, 2026

Creative Biolabs expands advanced single-cell multi-omics and RNA sequencing solutions to support biomedical discovery

September 9th, 2026|

Designed to meet the escalating demand for high-resolution cellular profiling, the upgraded suite offers end-to-end services ranging from single-cell transcriptome profiling to integrated multimodal and multi-omics workflows, empowering global researchers across oncology, immunology, and neuroscience. As life science research ...

309, 2026

New Johns Hopkins Study Identifies Pervasive RT-qPCR Artifact in CRISPR Knockdown Studies and How UltraMarathonRT® Solves It

September 3rd, 2026|

Guide RNAs from RNA-targeting CRISPR systems remain bound to their target mRNA after total RNA preparations and suppress conventional reverse transcription. uMRT's strand-displacing reverse transcriptase restores accurate knockdown quantification. RNAConnect, a life science company providing next- generation tools to ...

209, 2026

Lexogen Expands NGS Services with GCLP-Compliant Workflows

September 2nd, 2026|

Lexogen, a specialist in RNA sequencing technologies and next-generation sequencing services, announces the availability of designated NGS service workflows operated in compliance with the principles of the World Health Organization's Good Clinical Laboratory Practice guidance. The offering is designed for clinical research and clinical-trial projects requiring ...

Publications Trend

Submit a Post to the Blog

SUBMIT CONTENT

Subscribe to the RNA-Seq Blog

RNA-Seq Products & Services

Go to Top